You have 9 free searches left this month | for more free features.

Cefepime

Showing 1 - 25 of 118

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Cesarean Section; Infection Trial in Bani Suwayf (Cefepime 1000 MG, Ampicillin-sulbactam)

Active, not recruiting
  • Cesarean Section; Infection
  • Banī Suwayf, Beni Suef, Egypt
    Beni-suef university Hospital
Sep 16, 2023

Complicated Urinary Tract Infection Trial in Worldwide (cefepime and enmetazobactam combination)

Not yet recruiting
  • Complicated Urinary Tract Infection
  • cefepime and enmetazobactam combination
  • Hradec Králové, Czechia
  • +5 more
Apr 21, 2023

Complicated Urinary Tract Infection, Acute Pyelonephritis Trial in Meegomäe (co-administration of cefepime and nacubactam,

Recruiting
  • Complicated Urinary Tract Infection
  • Acute Pyelonephritis
  • co-administration of cefepime and nacubactam
  • +2 more
  • Meegomäe, Voru, Estonia
    Meiji Research Site
May 24, 2023

Complicated Urinary Tract Infection, Acute Pyelonephritis, Hospital-acquired Bacterial Pneumonia Trial in Nankoku

Recruiting
  • Complicated Urinary Tract Infection
  • +4 more
  • co-administration of cefepime and nacubactam
  • +2 more
  • Nankoku, Kochi, Japan
    Meiji Research Site
Jun 6, 2023

Cefepime vs. Carbapenems for Treating AmpC ß-lactamase-producing

Recruiting
  • Bacteremia
    • Strasbourg, France
      Service des maladies infectieuses et tropicales - CHU de Strasbo
    Sep 6, 2022

    Healthy Subjects Trial in Phoenix (cefepime-taniborbactam)

    Completed
    • Healthy Subjects
    • Phoenix, Arizona
      Pulmonary Associates PA
    Sep 30, 2021

    Pneumonia Trial in Gainesville (Cefepime, Meropenem, or Piperacillin/Tazobactam)

    Recruiting
    • Pneumonia
    • Cefepime, Meropenem, or Piperacillin/Tazobactam
    • Gainesville, Florida
      University of Florida
    Feb 24, 2022

    Pharmacokinetics Trial in Nanjing (Group 1:YK-1169, Group 2:YK-1169/Placebo Injection, Group 3:YK-1169/Placebo)

    Completed
    • Pharmacokinetics
    • Group 1:YK-1169
    • +5 more
    • Nanjing, Jiangsu, China
      辛玉霞
    Oct 18, 2022

    Endovascular Infection, Bone and Joint Infection, Skin and Soft Tissue Infection Trial in Morgantown (Amoxicillin,

    Not yet recruiting
    • Endovascular Infection
    • +5 more
    • Amoxicillin, amoxicillin-clavulanate, cefadroxil, cefpodoxime, cefalexin, ciprofloxacin, delafloxacin, doxycycline, levofloxacin, linezolid
    • Ampicillin, ampicillin-sulbactam, cefazolin, cefepime, ceftaroline, ceftazidime, ceftazidime-avibactam, dalbavancin, daptomycin, ertapenem
    • Morgantown, West Virginia
      West Virginia University
    Jul 24, 2023

    Clinical Efficacy and Neurotoxicity in Febrile Neutropenia

    Active, not recruiting
    • Pharmacokinetics
    • +2 more
      • Leuven, Vlaams-Brabant, Belgium
        University Hospitals Leuven
      Apr 26, 2021

      Febrile Neutropenia Trial in Melbourne (Piperacillin and Tazobactam for Injection, Cefepime Injection, Ceftazidime Injection)

      Recruiting
      • Febrile Neutropenia
      • Piperacillin and Tazobactam for Injection
      • +5 more
      • Melbourne, Victoria, Australia
        Royal Children's Hospital
      Nov 23, 2021

      Complicated Urinary Tract Infection, Acute Pyelonephritis Trial in Worldwide (Cefepime-zidebactam (FEP-ZID), Meropenem)

      Not yet recruiting
      • Complicated Urinary Tract Infection
      • Acute Pyelonephritis
      • Chula Vista, California
      • +44 more
      May 9, 2022

      Urinary Tract Infections, Acute Pyelonephritis Trial in Worldwide (Cefepime/VNRX-5133 (taniborbactam), Meropenem)

      Completed
      • Urinary Tract Infections
      • Acute Pyelonephritis
      • Buena Park, California
      • +77 more
      Dec 8, 2022

      Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor Trial in Houston (Cefepime, Imipenem/cilastatin-relebactam,

      Recruiting
      • Hematopoietic and Lymphoid Cell Neoplasm
      • Malignant Solid Neoplasm
      • Cefepime
      • +6 more
      • Houston, Texas
        M D Anderson Cancer Center
      Jul 21, 2022

      Endocarditis Trial in Morgantown (Amoxycillin, Cefalexin, Dicloxacillin, Linezolid, Levofloxacin, Rifampicin, Ampicillin,

      Recruiting
      • Endocarditis
      • Amoxycillin, Cefalexin, Dicloxacillin, Linezolid, Levofloxacin, Rifampicin
      • Ampicillin, Oxacillin, Vancomycin, Daptomycin, Ceftriaxone, Cefepime, Ceftaroline
      • Morgantown, West Virginia
        West Virginia University Medicine
      Feb 18, 2022

      Aspiration, Aspiration Pneumonia Trial in Farmington (Ceftriaxone, Amoxicillin clavulanic acid, Cefepime)

      Recruiting
      • Aspiration
      • Aspiration Pneumonia
      • Farmington, Connecticut
        UConn Health, John Dempsey Hospital
      Dec 3, 2021

      Pathogenic Bacteria Isolated in Public Hospitals in Northern

      Completed
      • Bacterial Infections
      • +2 more
      • Irbid, Jordan
        Yarmouk University
      Oct 24, 2021

      Antibiotic Plasma Concentrations During Continuous Renal

      Recruiting
      • Hemodiafiltration
      • +2 more
      • Continuous venovenous hemodiafiltration with high adsorption membrane (oXiris®)
      • Antibiotics
      • Barcelona, Spain
        Helena Colom Codina
      Sep 1, 2021

      Determining Optimal Beta-lactam Plasma Concentrations Through

      Recruiting
      • Beta-lactam Antibiotics
      • +10 more
      • The study is observational.
      • Geneva, Switzerland
        Geneva University Hospitals
      May 25, 2021

      Severe Bacterial Infections Trial in Milan (Cefepime, Piperacillin/tazobactam, Meropenem)

      Not yet recruiting
      • Severe Bacterial Infections
      • Cefepime
      • +3 more
      • Milan, Italy
        ASST Santi Paolo Carlo - San Carlo Borromeo Hospital - SSd Onco-
      Mar 24, 2021

      Healthy Subjects Trial in Liverpool (Cefepime 2 gram)

      Completed
      • Healthy Subjects
      • Cefepime 2 gram
      • Liverpool, United Kingdom
        University of Liverpool
      Jul 13, 2020

      Complicated Urinary Tract Infection, Acute Pyelonephritis Trial (FEP-TAZ 4 g, Meropenem, ciprofloxacin 500 mg Optional Oral

      Withdrawn
      • Complicated Urinary Tract Infection
      • Acute Pyelonephritis
      • FEP-TAZ 4 g
      • +3 more
      • (no location specified)
      Oct 6, 2020

      Febrile Neutropenia Trial in Hospitalet de Llobregat (Piperacillin-Tazobactam 4 g-0.5 g, Cefepime 2000 mg, Meropenem 1000 mg)

      Unknown status
      • Febrile Neutropenia
      • Piperacillin-Tazobactam 4 g-0.5 g
      • +2 more
      • Hospitalet de Llobregat, Barcelona, Spain
        Hospital Duran i Reynals
      Feb 11, 2021

      Neutropenia, Febrile, Leukemia, Pediatric Cancer Trial in Jakarta Pusat (Ceftazidime Injection, Cefepime Injection)

      Completed
      • Neutropenia, Febrile
      • +3 more
      • Ceftazidime Injection
      • Cefepime Injection
      • Jakarta Pusat, DKI Jakarta, Indonesia
        Cipto Mangunkusumo General Hospital
      Dec 5, 2019

      Febrile Neutropenia Trial in Winston-Salem (Meropenem, Micafungin)

      Not yet recruiting
      • Febrile Neutropenia
      • Winston-Salem, North Carolina
        Wake Forest University Health Sciences
      Mar 13, 2023